1. (a) The following medical conditions are eligible for services through the GHPP program:

   1. (1) Hemophilia, which includes any congenital hereditary hemorrhagic state due to a defect in the hemostatic mechanism resulting from a deficiency or abnormality in one of the plasma clotting factors or platelets including:

      1. (A) Factor I deficiency
      2. (B) Factor II deficiency
      3. (C) Factor V deficiency
      4. (D) Factor VII deficiency
      5. (E) Factor VIII deficiency
      6. (F) Factor IX deficiency
      7. (G) Factor X deficiency
      8. (H) Factor XI deficiency
      9. (I) Factor XIII deficiency
      10. (J) von Willebrand's Disease
      11. (K) Congenital hereditary platelet deficiency diseases or dysfunction such as congenital thrombasthenia (Glanzman's thrombasthenia) and thrombocytopathia
   2. (2) Cystic fibrosis

   3. (3) Hemoglobinopathies with anemia including:

      1. (A) Sickle Cell Disease, but not sickle cell trait
      2. (B) Thalassemia

   4. (4) Chronic degenerative neurological diseases:

      1. (A) Huntington's Disease
      2. (B) Joseph's Disease

      3. (C) Friedreich's Ataxia, genetic ataxias due to spinocerebellar degeneration.

         1. 1. Hereditary spastic paraplegia
         2. 2. Roussy-Levy Syndrome
         3. 3. Olivopontocerebellar degeneration
         4. 4. Refsum's disease
         5. 5. Charcot-Marie-Tooth Syndrome

   5. (5) The following metabolic diseases:

      1. (A) Disorder of amino-acid transport and metabolism

         1. 1. Phenylketonuria

         2. 2. Other disturbances of armoatic amino-acid metabolism

            1. a. Tyrosinemia

         3. 3. Disturbances of branched chain amino-acid metabolism

            1. a. Disturbances of metabolism of leucine, isoleucine, valine
            2. b. Hypervalinemia
            3. c. Intermittent branched-chain ketonuria
            4. d. Leucine-induced hypoglycemia
            5. e. Leucinosis
            6. f. Maple syrup urine disease
            7. g. Propionic and methylmalonic acidemias
            8. h. Lactic and pyruvate metabolism disorders
            9. i. Hereditary orotic (pyrimidine acidemia)

         4. 4. Disturbances of sulphur bearing amino-acid metabolism

            1. a. Homocystinuria
            2. b. Hypermethioninemia

         5. 5. Urea cycle disorders

            1. a. Argininosuccinic aciduria
            2. b. Citrullinemia
            3. c. Disorders of metabolism of ornithine, citrulline, argininossuccinic acid, arginine, and ammonia
            4. d. Hyperammonemia
            5. e. Hyperornithinemia

      2. (B) Disorders of carbohydrate transport and metabolism

         1. 1. Galactosemia

            1. a. Galactose-1-phosphate uridyl transferase deficiency
            2. b. Galactosuria

      3. (C) Disorders of copper metabolism

         1. 1. Wilson's disease

Note: Authority cited: Sections 208(a) and 341, Health and Safety Code. Reference: Sections 341 and 341.5, Health and Safety Code.

History

1. New section filed 12-28-87 as an emergency; operative 12-28-87 (Register 88, No. 2). A Certificate of Compliance must be transmitted to OAL within 120 days or emergency language will be repealed on 4-27-88.

2. Certificate of Compliance transmitted to OAL 4-4-88 and filed 5-4-88 (Register 88, No. 19).